Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Toxicol Appl Pharmacol ; 329: 140-147, 2017 08 15.
Artículo en Inglés | MEDLINE | ID: mdl-28579250

RESUMEN

Several novel mechanistic findings regarding to arsenic's pathogenesis has been reported and some of them suggest that the etiology of some arsenic induced diseases are due in part to heritable changes to the genome via epigenetic processes such as DNA methylation, histone maintenance, and mRNA expression. Recently, we reported that arsenic exposure during in utero and early life was associated with impairment in the lung function and abnormal receptor for advanced glycation endproducts (RAGE), matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) sputum levels. Based on our results and the reported arsenic impacts on DNA methylation, we designed this study in our cohort of children exposed in utero and early childhood to arsenic with the aim to associate DNA methylation of MMP9, TIMP1 and RAGE genes with its protein sputum levels and with urinary and toenail arsenic levels. The results disclosed hypermethylation in MMP9 promotor region in the most exposed children; and an increase in the RAGE sputum levels among children with the mid methylation level; there were also positive associations between MMP9 DNA methylation with arsenic toenail concentrations; RAGE DNA methylation with iAs, and %DMA; and finally between TIMP1 DNA methylation with the first arsenic methylation. A negative correlation between MMP9 sputum levels with its DNA methylation was registered. In conclusion, arsenic levels were positive associated with the DNA methylation of extracellular matrix remodeling genes;, which in turn could modifies the biological process in which they are involved causing or predisposing to lung diseases.


Asunto(s)
Intoxicación por Arsénico/genética , Arsénico/efectos adversos , Metilación de ADN/efectos de los fármacos , Matriz Extracelular/metabolismo , Metaloproteinasa 9 de la Matriz/genética , Receptor para Productos Finales de Glicación Avanzada/genética , Inhibidor Tisular de Metaloproteinasa-1/genética , Contaminantes Químicos del Agua/efectos adversos , Factores de Edad , Intoxicación por Arsénico/diagnóstico , Intoxicación por Arsénico/orina , Niño , Femenino , Marcadores Genéticos , Humanos , Masculino , Exposición Materna/efectos adversos , Metaloproteinasa 9 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/orina , Uñas/química , Embarazo , Efectos Tardíos de la Exposición Prenatal , Regiones Promotoras Genéticas , Receptor para Productos Finales de Glicación Avanzada/metabolismo , Medición de Riesgo , Esputo/química , Inhibidor Tisular de Metaloproteinasa-1/metabolismo , Inhibidor Tisular de Metaloproteinasa-1/orina , Abastecimiento de Agua
2.
J Appl Toxicol ; 37(10): 1195-1202, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28524356

RESUMEN

The Hippo pathway regulates cell proliferation and apoptosis and it has been noted that loss of critical components of this pathway can lead to uncontrolled cell growth. Yes-associated protein (YAP) is an important component of this Hippo pathway because YAP is the nuclear effector of the Hippo tumor suppressor pathway and it is crucial for the response to oxidative stress induced by cellular process and by different xenobiotics, including arsenic. It has been proposed that YAP dysregulation can contribute to a malignant cellular phenotype acting as both a tumor suppressor and an oncogene. The aim of the study was to assess and compare the expression of YAP in neoplastic and non-neoplastic breast tissue of women chronically exposed to arsenic through drinking water. YAP expression was assessed by immunohistochemistry in 120 breast biopsies from women with breast cancer and from women with other non-neoplastic breast pathologies. Arsenic concentration was quantified in urine. The results disclosed a significant lower percentage of cytoplasm YAP expression in cases and that YAP high-intensity staining in the cytoplasm but not in the nucleus decreases the risk for breast cancer. In conclusion, our overall data suggest that YAP may act as a tumor suppressor protein because their reduced expression in cases, which can induce an environment favorable for inhibition of apoptosis and promoting cellular proliferation by increasing genetic instability of cells, which might contribute to the pathogenesis of cancer. Copyright © 2017 John Wiley & Sons, Ltd.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/metabolismo , Arsénico/orina , Neoplasias de la Mama/genética , Fosfoproteínas/metabolismo , Proteínas Adaptadoras Transductoras de Señales/genética , Adulto , Antropometría , Arsénico/toxicidad , Mama/efectos de los fármacos , Mama/metabolismo , Neoplasias de la Mama/inducido químicamente , Línea Celular Tumoral , Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Proliferación Celular/efectos de los fármacos , Estudios Transversales , Citoplasma/metabolismo , Femenino , Humanos , Inmunohistoquímica , Estilo de Vida , Persona de Mediana Edad , Fosfoproteínas/genética , Factores Socioeconómicos , Encuestas y Cuestionarios , Factores de Transcripción , Proteínas Supresoras de Tumor/genética , Proteínas Supresoras de Tumor/metabolismo , Proteínas Señalizadoras YAP
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA